-
Polycystic ovarian syndrome patients with normospermic partners undergoing ovulation induction with letrozole had a higher live birth rate and no increase in adverse outcomes than women who received clomiphene citrate.
-
According to this pharmacokinetic study, the cyclic use of 20 mcg ethinyl estradiol oral contraceptives is problematic for obese women. Ovarian activity was better suppressed with continuous use (omitting the hormone-free interval) of the same dose oral contraceptive or increasing to a higher dose 30 mcg ethinyl estradiol oral contraceptive
-
A large prospective cohort study of perineal talc use demonstrated no increased risk of ovarian cancer overall or within any histological subtype. In addition, no association with talc application method was observed.
-
You reviewed the instructions for initiating the first pack of oral contraceptives (OCs) with your patient. She elects to use the Sunday start, beginning pills on the first Sunday after her next period. When she returns for a follow-up visit in a few months, though, you discover she never started the pills and now is pregnant.
-
Since about one-fourth of all U.S. women ages 15-44 who have ever married have undergone tubal sterilization,1 chances are that you have counseled women about their permanent contraceptive options.
-
Your patient is a young mother in a mutually monogamous relationship who cannot tolerate oral contraceptives, has heavy menses, and says she doesnt want to use an injectable birth control method. She has no medical insurance coverage. What options can you offer her?
-
American women now have a choice when it comes to permanent birth control: They can opt to undergo tubal ligation or choose the Essure transcervical sterilization procedure.
-
Who should not use Essure?
-
Review the number of patients who came through your examination room today, and count how many were screened for one or more sexually transmitted diseases (STDs). If the answer is zero, then perhaps it is time to review your practice guidelines.
-
Your next patient, a 19-year-old woman who is sexually active, says she douches on a weekly basis for hygiene purposes. She has been previously treated for a sexually transmitted disease (STD). What should you tell her?
